nafamostat has been researched along with Sensitivity and Specificity in 2 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Sensitivity and Specificity: Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
Excerpt | Relevance | Reference |
---|---|---|
"The Japanese severity score (JSS) for acute pancreatitis was revised in 2008." | 1.35 | Utility of the new Japanese severity score and indications for special therapies in acute pancreatitis. ( Kamei, K; Ku, Y; Kuroda, Y; Ohyanagi, H; Satoi, S; Sawa, H; Shinzeki, M; Takeyama, Y; Ueda, T; Yasuda, T, 2009) |
" The pharmacokinetic parameters were also estimated and compared with those of Japanese volunteers (slightly lower plasma concentration and longer terminal elimination half-life for Chinese volunteers)." | 1.35 | A method for quantifying the unstable and highly polar drug nafamostat mesilate in human plasma with optimized solid-phase extraction and ESI-MS detection: more accurate evaluation for pharmacokinetic study. ( Cao, YG; Chen, YC; Liu, XQ; Shao, JP; Yu, D; Zhang, M, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ueda, T | 1 |
Takeyama, Y | 1 |
Yasuda, T | 1 |
Kamei, K | 1 |
Satoi, S | 1 |
Sawa, H | 1 |
Shinzeki, M | 1 |
Ku, Y | 1 |
Kuroda, Y | 1 |
Ohyanagi, H | 1 |
Cao, YG | 1 |
Zhang, M | 1 |
Yu, D | 1 |
Shao, JP | 1 |
Chen, YC | 1 |
Liu, XQ | 1 |
2 other studies available for nafamostat and Sensitivity and Specificity
Article | Year |
---|---|
Utility of the new Japanese severity score and indications for special therapies in acute pancreatitis.
Topics: Acute Disease; Benzamidines; Enteral Nutrition; Female; Guanidines; Humans; Infusions, Intra-Arteria | 2009 |
A method for quantifying the unstable and highly polar drug nafamostat mesilate in human plasma with optimized solid-phase extraction and ESI-MS detection: more accurate evaluation for pharmacokinetic study.
Topics: Adult; Benzamidines; Calibration; Drug Stability; Female; Guanidines; Humans; Hydrogen-Ion Concentra | 2008 |